Gregory K. Palm

Director/Board Member at Olatec Therapeutics LLC

75 year

Finance

Consumer Services

Health Technology

Profile

Gregory K.
Palm is currently a Director at Olatec Therapeutics LLC since 2021.
Previously, he worked as Secretary, Executive VP & General Counsel at The Goldman Sachs Group, Inc. from 2011 to 2018.
He completed his undergraduate degree at Massachusetts Institute of Technology and his graduate and MBA degrees at Harvard Business School.

Gregory K. Palm active positions

Companies	Position	Start
Olatec Therapeutics LLC Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation.	Director/Board Member	2021-07-28

All active positions of Gregory K. Palm

Former positions of Gregory K. Palm

Companies	Position	End
THE GOLDMAN SACHS GROUP, INC.	General Counsel	-

See the detail of Gregory K. Palm's experience

Training of Gregory K. Palm

Massachusetts Institute of Technology	Undergraduate Degree
Harvard Business School	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory K. Palm's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
THE GOLDMAN SACHS GROUP, INC.	Finance

Private companies	1
Olatec Therapeutics LLC Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation.	Health Technology